-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, ChVGvuv37fgwI4EtmGoaFKcaOlrsQ/Jy7NwI3YwGEJZnKWNgpMJeqs3coL2TzrdJ ibIGNfUKHh78wh2RI0WIkA== 0000950117-00-000275.txt : 20000214 0000950117-00-000275.hdr.sgml : 20000214 ACCESSION NUMBER: 0000950117-00-000275 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20000211 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: CUBIST PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000912183 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 223192085 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: SEC FILE NUMBER: 005-47321 FILM NUMBER: 536026 BUSINESS ADDRESS: STREET 1: 24 EMILY ST CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6075761999 MAIL ADDRESS: STREET 1: 24 EMILY ST CITY: CAMBRIDGE STATE: MA ZIP: 02139 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BRISTOL MYERS SQUIBB CO CENTRAL INDEX KEY: 0000014272 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 220790350 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 345 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10154 BUSINESS PHONE: 2125464000 MAIL ADDRESS: STREET 1: 345 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10154 FORMER COMPANY: FORMER CONFORMED NAME: BRISTOL MYERS CO DATE OF NAME CHANGE: 19891012 SC 13G/A 1 BRISTOL-MYERS SQUIBB COMPANY 13G/A Page 1 of 6 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 1) Cubist Pharmaceuticals, Inc. ------------------------------------------------------------------------------ (Name of Issuer) Common Stock, $.001 par value ------------------------------------------------------------------------------ (Title of Class of Securities) 229678107 ------------------------------------------------------------------------------ (CUSIP Number) The information required on the remainder of this cover page shall not be deemed to be "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section of the Exchange Act but shall be subject to all other provisions of the Exchange Act. Page 2 of 6 SCHEDULE 13G - ------------------------- CUSIP No. 229678107 - ------------------------- 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON BRISTOL-MYERS SQUIBB COMPANY I.R.S. Employer Identification Number 22-079-0350 - ------------------------------------------------------------------------------ 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [_] (b) [X] - ------------------------------------------------------------------------------ 3 SEC USE ONLY - ------------------------------------------------------------------------------ 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware - ------------------------------------------------------------------------------ NUMBER OF 5 SOLE VOTING POWER SHARES 0 BENEFICIALLY ---------------------------- OWNED BY 6 SHARED VOTING POWER EACH 0 REPORTING ---------------------------- PERSON 7 SOLE DISPOSITIVE POWER 0 ----------------------------- 8 SHARED DISPOSITIVE POWER 0 - ------------------------------------------------------------------------------ 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 0 - ------------------------------------------------------------------------------ 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [_] - ------------------------------------------------------------------------------ 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 0% - ------------------------------------------------------------------------------ 12 TYPE OF REPORTING PERSON CO - ------------------------------------------------------------------------------ Page 3 of 6 - ------------------------- CUSIP NO. 229678107 - ------------------------- Item 1(a). Name of Issuer: Cubist Pharmaceuticals, Inc. Item 1(b). Address of Issuer's Principal Executive Offices: 24 Emily Street, Cambridge, Massachusetts 02139 Item 2(a). Name of Person Filing: Bristol-Myers Squibb Company Item 2(b). Address of Principal Business Office or, if None, Residence: 345 Park Avenue, New York, NY 10154 Item 2(c). Citizenship: Delaware Item 2(d). Title of Class of Securities: Common Stock, $.001 par value per share Item 2(e). CUSIP Number: 229678107 Item 3. If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b), check whether the person filing is a: (a) [_] Broker or dealer registered under Section 15 of the Act; (b) [_] Bank as defined in Section 3(a)(6) of the Act; (c) [_] Insurance Company as defined in Section 3(a)(19) of the Act; (d) [_] Investment Company registered under Section 8 of the Investment Company Act; (e) [_] Investment Adviser registered under Section 203 of the Investment Advisers Act of 1940; (f) [_] Employee Benefit Plan, Pension Fund which is subject to the provisions of the Employee Retirement Income Security act of 1974 or Endowment Fund; see 13d-1(b)(1)(ii)(F); (g) [_] Parent Holding Company, in accordance with Rule 13d-1(b)(i)(G); see Item 7; (h) [_] Group, in accordance with Rule 13d-1(b)(1)(ii)(H). Page 4 of 6 - ------------------------- CUSIP NO. 229678107 - ------------------------- Item 4. Ownership. If the percent of the class owned, as of December 31 of the year covered by the statement, or as of the last day of any month described in Rule 13d-1 (b)(2), if applicable, exceeds five percent, provide the following information as of that date and identify those shares which there is a right to acquire. (a) Amount beneficially owned: 0 ------------------------------------------------------- (b) Percent of class: 0% ------------------------------------------------------- (c) Number of shares as to which such person has: (i) Sole power to vote or to direct the vote 0 , ---------- (ii) Shared power to vote or to direct the vote 0 , ---------- (iii) Sole power to dispose or to direct the disposition of 0 , ---------- (iv) Shared power to dispose or to direct the disposition of 0 , ---------- Item 5. Ownership of Five Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [X]. Item 6. Ownership of More Than Five Percent on Behalf of Another Person. Not Applicable. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company. Not Applicable. Item 8. Identification and Classification of Members of the Group. Not Applicable. Item 9. Notice of Dissolution of Group. Not Applicable. Page 5 of 6 - ------------------------- CUSIP NO. 229678107 - ------------------------- Item 10. Certification. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were not acquired for the purpose of and do not have the effect of changing or influencing the control of the issuer of such securities and were not acquired in connection with or as a participant in any transaction having such purpose or effect. Page 6 of 6 SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this Statement is true, complete and correct. Dated: February 11, 2000 BRISTOL-MYERS SQUIBB COMPANY ------------------- By: /s/ Robert E. Ewers, Jr. ------------------------ Robert E. Ewers, Jr. Senior Counsel and Assistant Secretary -----END PRIVACY-ENHANCED MESSAGE-----